Impact (REF3a/b)

Impact template (REF3a)

Download template (131K)

All impact case studies

Download all case studies (1.2MB)

Individual case studies

Delivering better birthdays: research-based training programme makes labour and birth safer for babies and mothers across the world (131K)

Expressed hERG potassium channel bioassays in mammalian cell lines to evaluate safety and efficacy of new drugs (135K)

Health benefits, increased public awareness and changes in national policy result from the successful implantation of the first tissue-engineered trachea, created utilising the patient’s own stem cells (124K)

Lower risks to patients, advances in international practice and substantial resource savings result from ‘beating heart’ off-pump coronary artery bypass surgery (144K)

Minimal residual disease assessment in acute lymphoblastic leukaemia allows safe individualisation of chemotherapy and reduction of treatment toxicity (106K)

New businesses, commercial investment and adoption of new technology result from antigen-specific peptide immunotherapy development (121K)

Substantial changes in worldwide healthcare policy and the practice of joint replacement result from research into the failure rates of and systemic effects of metal-on-metal hip replacements (194K)

Translating research into novel immunotherapies delivers scientific and economic gains for the pharmaceutical/biotechnology sector in drug discovery (59K)

Use of aspirin and high dietary fibre to prevent and reduce deaths from bowel and other cancers, influencing global policy on cancer prevention and major public health campaigns (‘five-a-day’) (284K)